Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Phase 1/2 Recruiting
20 enrolled
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Phase 1/2 Recruiting
54 enrolled
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Phase 1/2 Suspended
54 enrolled
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Phase 1/2 Recruiting
62 enrolled
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Phase 1/2 Recruiting
62 enrolled
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG
Phase 1/2 Completed
24 enrolled
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Phase 1/2 Completed
36 enrolled
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
AXL1717
Phase 1/2 Terminated
10 enrolled 8 charts
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
Phase 1/2 Terminated
13 enrolled 6 charts
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Phase 1/2 Completed
33 enrolled
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Phase 1/2 Terminated
21 enrolled 8 charts
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
Phase 1/2 Completed
23 enrolled
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Phase 1/2 Unknown
50 enrolled
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1/2 Completed
122 enrolled 11 charts
Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1/2 Completed
35 enrolled 13 charts
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Phase 1/2 Terminated
12 enrolled 12 charts
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Phase 1/2 Completed
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
Phase 1/2 Completed
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Phase 1/2 Completed
105 enrolled
CCI-779 in Treating Patients With Malignant Glioma
Phase 1/2 Completed
49 enrolled
Phase I/II Cabazitaxel for Recurrent Malignant Glioma
Phase 1/2 Withdrawn
Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Phase 1/2 Completed
11 enrolled 6 charts
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Phase 1/2 Completed
62 enrolled 15 charts
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Phase 1/2 Completed
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Phase 1/2 Completed
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Phase 1/2 Completed
30 enrolled
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Phase 1/2 Completed
10 enrolled
GLIO-TEP
Phase 1/2 Completed
21 enrolled